Skip to Main Content

INFORMATION FOR

MitraClip REPAIR MR Study

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.

  • Trial with
    Abbott Cardiovascular Systems, Inc.
  • Start Date
    11/01/2021
  • End Date
    02/28/2024

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000031013